Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States.

Theresa P Devasia Angela B Smith Yaw A Nyame Ruth B Etzioni

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)

Relatively similar fractions of de novo and recurrent MPC among prevalent cases highlight opportunities for early detection and management of localized disease in reducing the MPC burden. Changes in diagnostic technologies could lead to greater growth in MPC cases in the US than projected.

Keyphrases

prostate cancer
squamous cell carcinoma
small cell lung cancer
radical prostatectomy
climate change
middle aged
risk factors